31 Jul 2018 07:00
For immediate release
Ā
Circassia Pharmaceuticals plc
Ā
Total Voting Rights Update
Ā
Ā
Ā
31st July 2018
Ā
In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that the Company's issued share capital consists of 357,192,062 ordinary shares of 0.08p each in issue, each with equal voting rights. No shares are held in treasury.
Ā
The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.
Ā
-Ends-
Ā
For further information, please contact: | |
Ā Circassia Pharmaceuticals plc Julien Cotta, Company Secretary | Ā +44 (0) 1865 405560 |
Ā
Follow the stocks